Institutional investors purchased a net $769.3 thousand shares of EBS during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 68.07% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
S.A.C. CAPITAL ADVISORS LP Bought 323.1 Thousand shares of Emergent BioSolutions Inc
BLACKROCK FUND ADVISORS Bought 219.7 Thousand shares of Emergent BioSolutions Inc